Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729607 · ClinicalTrials.gov registry record · NA
Vertical Soft Tissue Augmentation With CTG vs ADM
A NA study of Implant Complication, sponsored by Harvard Medical School (HMS and HSDM).
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT05729607 is a NA study of Implant Complication that is actively recruiting participants, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 28 participants, below the 90-participant average among 3 other Implant Complication trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05729607, a NA study of Implant Complication, is actively recruiting participants, sponsored by Harvard Medical School (HMS and HSDM).
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims at comparing two different approaches for vertical soft tissue augmentation at implant sites exhibiting soft tissue dehiscences: autogenous connective tissue graft vs acellular dermal matrix + enamel matrix derivative
Conditions Studied
Interventions
- PROCEDURE Vertical soft tissue augmentation
Study Locations (1)
Massachusetts
- Harvard School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-05-26 |
| Est. Completion | 2027-11-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05729607
The ClinicalTrials.gov registry entry for NCT05729607 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 3 other Implant Complication trials with a reported enrollment target (69% lower). The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Implant Complication appearing as the primary indexed condition, and to 1 intervention - of which Vertical soft tissue augmentation is the first listed.
NCT05729607 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05729607 about?
NCT05729607 is a clinical study titled "Vertical Soft Tissue Augmentation With CTG vs ADM". The study aims at comparing two different approaches for vertical soft tissue augmentation at implant sites exhibiting soft tissue dehiscences: autogenous connective tissue graft vs acellular dermal matrix + enamel matrix derivative
What is the current status of trial NCT05729607?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2023-05-26. Estimated completion is 2027-11-27.
What conditions does trial NCT05729607 study?
This clinical trial studies the following conditions: Implant Complication.
What interventions are being tested in trial NCT05729607?
The interventions under investigation include: Vertical soft tissue augmentation (PROCEDURE).
Who is sponsoring clinical trial NCT05729607?
This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05729607 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Implant Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immediate Versus Delayed Loading of Maxillary Overdenture Implants
RECRUITING · NA
-
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
RECRUITING · NA
-
Collagen Matrix + rhPDGF-BB vs Connective Tissue Graft for the Treatment of Peri-implant Soft Tissue Dehiscences
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.